Source: Annual Congress 2002 - Biological disease markers in airways and parenchymal lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Bruni, F. Romamo, A. Mancuso, M. I. Scarlato, S. Barbera, N. P. Scarpelli (Cosenza, Italy). Dyspnoea in healthy smokers:its evaluation by cardiopulmonary exercise testing and bronchial cellularity. Eur Respir J 2002; 20: Suppl. 38, 3605

Member's Comments

No comment yet.

Related content which might interest you: Dyspnoea and cardiopulmonary functions in young asthmatics performing standardized exercise testing Source: Eur Respir J 2001; 18: Suppl. 33, 104s Year: 2001 Assessment of multiple dimensions of dyspnea during cardiopulmonary exercise testing (CPET) in healthy adults Source: International Congress 2019 – Cardiopulmonary exercise testing Year: 2019 Any role for cardiopulmonary exercise test in symptomatic smokers with borderline spirometry? Source: International Congress 2018 – Cardiopulmonary exercise testing in COPD and cardiovascular diseases Year: 2018 Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing Source: Eur Respir Rev 2016; 25: 333-347 Year: 2016 Pulmonary function and cardiopulmonary exercise tests in patients with bronchiectasis Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases Year: 2010 Acute effects of water-pipe smoking on pulmonary function and cardio-pulmonary exercise capacity in healthy subjects Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011 Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing Source: Eur Respir Rev 2017; 26: 160099 Year: 2017 Evaluation of exercise capacity and mechanisms of limitation during cardiopulmonary exercise testing (CPET) in patients with chronic hypersensitivity pneumonitis Source: International Congress 2018 – New methods and concepts in exercise testing Year: 2018 Patients with severe asthma show reduced exercise capacity assessed with cardiopulmonary exercise test. Source: International Congress 2019 – Cardiopulmonary exercise testing Year: 2019 Effects of smoking on exercise capacity, exercise dyspnea and pulmonary functions in healthy individuals Source: International Congress 2018 – Effect of tobacco use on health Year: 2018 The treatment of difficult asthmatics with no pulmonary cause for persistent symptoms on cardiopulmonary exercise testing (CPX) Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010 Cardiopulmonary exercise test in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 88s Year: 2003 Cardiopulmonary exercise testing in children with mild-moderate controlled asthma Source: Virtual Congress 2020 – Risk factors, comorbidities and remote monitoring in childhood asthma Year: 2020 Exercise testing in the diagnosis of dyspnea with normal resting lung function Source: Eur Respir J 2005; 26: Suppl. 49, 347s Year: 2005 Predicting exercise endurance in COPD patients by lung function testing Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy Year: 2010 Effect of exercise challenge on systemic inflammatory markers in healthy smokers and smokers with COPD Source: International Congress 2014 – Mechanisms of exercise limitation in health and disease Year: 2014 Resting physiological markers of exercise intolerance in smokers with mild airway obstruction Source: International Congress 2016 – Mechanisms of symptoms and exercise limitation in health and disease Year: 2016 Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients Source: Eur Respir J, 57 (1) 2004265; 10.1183/13993003.04265-2020 Year: 2021 Breathlessness on exercise: paediatric cardiopulmonary exercise test results Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new? Year: 2020 Oxygen kinetics during submaximal cardiopulmonary exercise testing (CPET) in adult patients with cystic fibrosis is related to Schwachman score Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010